Provider Authorization

This clinical prescription is restricted. Please enter the referral code provided by your clinician to access this formulation.

Invalid or expired code. Please try again.
Request Access
← Return to catalog
Semaglutide
Treatment

Semaglutide.a GLP-1 receptor agonist, available by prescription when appropriate.

★★★★★ 4.9
$—
Vial size 1MG (0.5MG/ML)
Pack size 1 vial (1ML)
Date of birth
Quantity
Ships 1–2 business days after approval
ClassSingle-target GLP-1 agonistSingle-target GLP-1 agonist.
Mol. weight4113.58 DaConfirmed on every batch shipped.
Half-life7 daysOnce-weekly dosing target.
—
Semaglutide
✓ Added 1× Semaglutide View cart →
— Mechanism / 01

Semaglutide put GLP-1 on the map. Compounded semaglutide, prepared by a licensed compounding pharmacy and prescribed only after a review by a US-licensed clinician. Each batch is tested by an independent lab before it ships.

GLP-1 receptor

Activation slows gastric emptying, suppresses appetite at the hypothalamic level, and improves insulin response — the three-way mechanism behind every GLP-1 outcome paper.

Effect · Primary

Albumin binding

A C-18 fatty acid side chain binds serum albumin, extending half-life to ~7 days. The engineering choice that made once-weekly GLP-1 dosing practical.

Effect · Secondary
— Reference prescription / 02

Titration schedule.

Your clinician sets and adjusts your dose.

Weeks 1–40.25 mg

Onboarding dose. Establishes tolerance before titrating up.

Weeks 5–80.5 mg

First step. Some patients stabilize here if 1.0+ becomes intolerable.

Weeks 9–121.0 mg

The most-cited maintenance dose for sub-clinical prescriptions.

Weeks 13+1.7–2.4 mg

Maintenance dose. Your clinician sets and adjusts your dose.

— Common questions / 05

Before you order.

Sema vs Element MD vs Tirz — when do I run sema?
Run sema when you want the most-studied molecule, the cleanest tolerability, and weekly dosing predictability. Tirz and Element MD have steeper curves; sema has the deepest paper trail.
Standard titration?
Standard Titration: 0.25 → 0.5 → 1.0 → 1.7 → 2.4mg, four weeks per step.
Independent COA?
Every batch passes testing. Latest report linked above.
How do I cancel a subscription?
From your account dashboard, in two clicks. No retention call, no email loop. Pause, skip, or cancel any time before the next ship date.

Important Safety Information

Before using this medication, review these safety guidelines. The specific medical text, full side effect profile, and patient counseling materials must be provided and reviewed by your prescribing clinician or dispensing pharmacy prior to treatment.

Contraindications & Warnings:
Do not use this medication if you have a known allergy to it or any of its ingredients.
Risk of Thyroid Tumors:
GLP-1 receptor agonist medications, such as semaglutide and tirzepatide, carry a boxed warning regarding the risk of thyroid C-cell tumors. Do not use these medications if you or anyone in your family has ever had Medullary Thyroid Carcinoma (MTC) or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Serious Risks:
Serious but rare side effects can occur. Please consult the full prescribing information for risks related to pancreatitis, gallbladder problems, kidney injury, low blood sugar (hypoglycemia), serious allergic reactions, and changes in vision.
Common Side Effects:
he most common side effects include mild-to-moderate nausea, vomiting, diarrhea, constipation, and stomach pain. These often improve over time.